Traders Buy Monsanto Co. (MON) on Weakness
Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading on Thursday. $47.89 million flowed into the stock on the tick-up and $32.77 million flowed out of the stock on the tick-down, for a money net flow of $15.12 million into the stock. Of all equities tracked, Monsanto had the 7th highest net in-flow for the day. Monsanto traded down ($0.02) for the day and closed at $105.92
Several brokerages recently weighed in on MON. Vetr cut Monsanto from a “hold” rating to a “sell” rating and set a $89.50 price target for the company. in a research report on Tuesday, April 19th. Zacks Investment Research upgraded Monsanto from a “strong sell” rating to a “hold” rating in a research report on Tuesday, May 3rd. Berenberg Bank set a $110.00 price target on Monsanto and gave the company a “buy” rating in a research report on Friday, May 13th. TheStreet upgraded Monsanto from a “hold” rating to a “buy” rating in a research report on Thursday, May 12th. Finally, Piper Jaffray Cos. reiterated an “overweight” rating on shares of Monsanto in a research report on Saturday, May 14th. Four investment analysts have rated the stock with a sell rating, six have given a hold rating, sixteen have issued a buy rating and one has given a strong buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $109.69.
The company’s 50-day moving average is $104.35 and its 200 day moving average is $97.14. The firm has a market cap of $46.05 billion and a price-to-earnings ratio of 46.32.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, June 29th. The company reported $2.17 earnings per share for the quarter, missing the consensus estimate of $2.40 by $0.23. The company earned $4.19 billion during the quarter, compared to analysts’ expectations of $4.49 billion. Monsanto’s quarterly revenue was down 8.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.39 earnings per share. On average, equities research analysts expect that Monsanto Co. will post $4.46 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be paid a $0.54 dividend. This represents a $2.16 annualized dividend and a yield of 2.05%.
In related news, COO Brett D. Begemann sold 27,980 shares of the firm’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the completion of the transaction, the chief operating officer now directly owns 102,480 shares of the company’s stock, valued at approximately $10,618,977.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Michael K. Stern sold 12,797 shares of the firm’s stock in a transaction that occurred on Wednesday, July 13th. The shares were sold at an average price of $101.77, for a total value of $1,302,350.69. Following the completion of the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The disclosure for this sale can be found here.
Other institutional investors have recently added to or reduced their stakes in the company. BlackRock Advisors LLC increased its position in Monsanto by 49.9% in the fourth quarter. BlackRock Advisors LLC now owns 1,138,888 shares of the company’s stock valued at $112,203,000 after buying an additional 379,225 shares during the last quarter. Dimensional Fund Advisors LP increased its position in Monsanto by 5.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 982,183 shares of the company’s stock valued at $96,767,000 after buying an additional 48,863 shares during the last quarter. US Bancorp DE increased its position in Monsanto by 0.4% in the fourth quarter. US Bancorp DE now owns 344,555 shares of the company’s stock valued at $33,946,000 after buying an additional 1,297 shares during the last quarter. KBC Group NV increased its position in Monsanto by 13.8% in the fourth quarter. KBC Group NV now owns 129,250 shares of the company’s stock valued at $12,733,000 after buying an additional 15,681 shares during the last quarter. Finally, Morningstar Investment Services LLC increased its position in Monsanto by 65.4% in the fourth quarter. Morningstar Investment Services LLC now owns 42,914 shares of the company’s stock valued at $4,228,000 after buying an additional 16,971 shares during the last quarter.
Monsanto Company (Monsanto) is a provider of agricultural products for farmers. The Company’s seeds, biotechnology trait products, and herbicides provide farmers with solutions that improve productivity, reduce the costs of farming, and produce better foods for consumers and better feed for animals. It manages business in two segments: Seeds and Genomics, and Agricultural Productivity.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.